CytoSorbents Corporation (CTSO)

[ANESRI]

Today's New York Times has a very interesting frontpage article on the pharmaceutical industry - it may be very very relevant to CTSO. A few points worth mentioning
-All the drug company's in Europe have been downgraded by M.Stanley because the operating environment is worsening rapidly because of multiple reasons - drought of bockbuster drug breakthroughs and research discoveries, pressure from insurance companies to hold down prices, thousands of layoffs in R&D and a new Fedral program to allow generic versions of expensive biologic drugs!
- Drug cos. executives are addressing calls for reinvention frm analyts who say the industry became too dependent on a business model built around blockbuster drugs.
Pfizer's president stated,"We have to fix our innovative core" His co. is refocusing on smaller niches in cancer, inflammation, neurosciences.

I would seriously recommend this article to all - we seem to be in a very timely market for the pharmaceutical industry to be interested in us.